Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
SPRC
SciSparc Ltd.
$4.75
Login to see SciSparc Ltd. (SPRC) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Chart
$1.8 (+163.89%)
$7.37 (-35.55%)
$0.31 (+1432.26%)
$0.23 (+1965.22%)
SPRC has Extreme Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Price under $5
High volatilty
SPRC overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
SPRC Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
SPRC Street view is extremely bullish and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displaySPRC Earnings
The TTM reflects 12-month period, providing review of SPRC financial performance.
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
What is SPRC current stock price?
What are SPRC stock strengths?
What risks are associated with SPRC stock?
When is SPRC next earnings report?
What is SPRC market cap and volume?
What is SPRC's current Stock IQ?
Should I buy SPRC stock right now?
Is SPRC a Strong Buy right now?
What does a 'Strong Buy' rating mean for SPRC?
What does a 'Strong Sell' rating mean for SPRC?
What factors influence SPRC's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
SPRC
SciSparc Ltd.
Current Price
$4.75
Stock Insights
Not Enough Information
Login to unlock SciSparc Ltd. (SPRC) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$1.8 (+163.89%)
$7.37 (-35.55%)
$0.31 (+1432.26%)
$0.23 (+1965.22%)
SPRC Analysts Opinion
SPRC Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
SPRC Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
SPRC Street view is extremely bullish and have negative views on the near-term outlook
SPRC has Extreme Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Price under $5
High volatilty
Average key support and resistance price levels.
Login to displaySPRC Earnings
The TTM data reflects the most recent 12-month period, providing overview of SPRC financial performance.
SPRC Financial Health
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
SPRC Latest Analysis
SciSparc Stocks Surge 50% In Pre-Market After N2OFF Approves MitoCareX Acquisition . (RTTNews) - Shares of SciSparc Ltd. (SPRC) are gaining over 58% in premarket trading on Tuesday on news that the stockholders of N2OFF Inc. (NITO) have approved the proposed acquisition of SciSparcs majority-owned subsidiary MitoCareX Bio Ltd.
Tue Sep 30, 2025
SciSparc: N2OFF Shareholders Approve Merger with SciSparcs Majority Owned Subsidiary MitoCareX a Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer. TEL AVIV Israel Sept. 29 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the Company or SciSparc) a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system today announced that on September 25 2025 the stockhol
Mon Sep 29, 2025
SciSparc Stock Surges As It Launches Initiative To Advance Drug Discovery With Quantum Algorithms. ) stock is surging on Thursday with a session volume of 58.21 million compared to the average volume of 2.49 million .SPRC stock is racing ahead of the pack. The specialty clinical-stage pharmaceutical company which focuses on the development of therapies to treat disorders of the central nervous system said on Thursday the board of directors had resolved to initiate the launch of an innovative ini
Thu Sep 25, 2025
SciSparc stock soars after launching quantum computing initiative.
Thu Sep 25, 2025
SciSparc Resolves to Launch Innovative Quantum Computing-Enabled 3D Protein Modeling Initiative to Revolutionize AI Drug Discovery. TEL AVIV Israel Sept. 25 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the Company or SciSparc) a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system today announced that the board of directors resolved to initiate the launch of an innovative initiative to advance 3D prote
Thu Sep 25, 2025
Why SciSparc (SPRC) Stock Is Skyrocketing Today. ) shares are trading sharply higher Wednesday morning after .The companies a merger agreement on April 10 2024. Investors are closely watching for developments as the new September 30 ...
Wed Sep 17, 2025
SciSparc stock rallies after AutoMax files motion on pending merger.
Wed Sep 17, 2025
SciSparc Stock Shoots Up Over 89% After Hours: Whats Going On?. ) shares soared 89.13% to $3.48 during after-hours trading on Tuesday following news of a court-granted stay in merger proceedings with Check out the current price of .The Jerusalem District Court has granted AutoMax’.s request to delay merger proceedings until September 30 according to an SEC filing by SciSparc. AutoMax which specializes in manufacturing automotive solutions asked for the postponement due to concerns about its
Wed Sep 17, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
SPRC Stock trends
SPRC Stock performance
SPRC Stock analysis
SPRC investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings